FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20180816E00328
1. Date of relevant event: 08/08/2018
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 06160
4. Name of listed corporation: BeiGene, Ltd. - B 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 767,163,184
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Wang
(Other names) Xiaodong
10. Name of director (Chinese): 王曉東 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1701Miscellaneous
On listing of the corporation or a class of shares of the listed corporation
 
 
2501Other (you must describe the capacity in the Supplementary Information box)
 		 21,483,959         
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
   
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position21,483,9592.80
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2101Beneficial owner
Long position16,259,587
2203Interest of your child under 18 years of age
Long position224,372
2201Interest of corporation controlled by you
Long position5,000,000
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
Long position
4105Unlisted derivatives - Physically settled
20/05/201120/05/2021USD0    88,235
Long position
4105Unlisted derivatives - Physically settled
03/04/201303/04/2023USD0    879,267
Long position
4105Unlisted derivatives - Physically settled
29/06/201529/06/2025USD0    500,000
Long position
4105Unlisted derivatives - Physically settled
16/11/201615/11/2026USD0    1,613,430
Long position
4105Unlisted derivatives - Physically settled
27/09/201726/09/2027USD0    750,000
Long position
4105Unlisted derivatives - Physically settled
26/06/201825/06/2028USD0    655,044
Long position
4105Unlisted derivatives - Physically settled
19/07/201519/07/2025USD0    3,800,167
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
        401,641
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
ChildDaniel C Wang
Long position224,372
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Wang Investment LLC10700 NE 4th Street, Unit 3516, Bellevue, WA 98004, USAXiaodong Wang99.00Y
Long position5,000,000
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Box 24: Beneficial owner (16,259,587), interest of Dr. Wang's child under 18 years of age (224,372) and interest of controlled corporation (5,000,000). Box 28: the interest in 401,641 shares derives from the restricted share units granted pursuant to the equity plans of BeiGene, Ltd. Box 30: Wang Investment LLC is owned as to 99% by two grantor retained annuity trusts, of which Dr. Wang is the beneficiary.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 16/08/2018
(dd/mm/yyyy)